FSSAI Pulls Up Dr Reddy's, Nestle Health Science Over Celevida Claims

The Food Safety and Standards Authority of India (FSSAI) has taken action against Dr Reddy's and Nestle Health Science. The FSSAI "pulled up" both companies concerning advertising claims made about their product, Celevida.

The FSSAI stated that Celevida was advertised as providing high-protein support. This support was specifically for preserving lean muscle.

These claims were linked to the product's use during GLP-1/GIP therapies. Such therapies are commonly employed in weight-loss treatment protocols.

What to watch: Potential responses from Dr Reddy's and Nestle Health Science.

Editor's note: The draft accurately captures the essence of the report, though it could have been slightly more integrated rather than using short, choppy sentences.